Caption Management’s Neuronetics STIM Stock Holding History

Caption Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,400	Closed	-$46K	–	1922
2021 Q4	$46K	Hold	10,400	–	–	﹤0.01%	1513
2021 Q3	$68K	Buy	+10,400	New	+$99.8K	﹤0.01%	1425

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caption Management's STIM Position: Q1 2026 in Review

Caption Management sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 92,501 shares — an estimated $128K sold.

Caption Management first reported a position in STIM in Q3 2021 and held it in 4 quarters. The position peaked at $235K in Q3 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

Caption Management reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
Caption Management sold 92,501 Neuronetics shares in Q1 2026, an estimated $128K.
Caption Management first reported a position in Neuronetics in Q3 2021 and held it in 4 quarters.
Caption Management's Neuronetics position peaked at $235K in Q3 2021.
99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.